SC
USNA icon

Schubert & Co’s Usana Health Sciences USNA Stock Holding History

Schubert & Co’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$629 – 1451
2023
Q1 		$629 Buy
10
+3
+43% +$179 ﹤0.01% 1354
2022
Q4 		$372 Buy
7
+4
+133% +$217 ﹤0.01% 1442
2022
Q3 		$0 Sell
3
-4
-57% -$264 ﹤0.01% 1594
2022
Q2 		$1K Buy
7
+5
+250% +$372 ﹤0.01% 1336
2022
Q1 		$0 Buy
+2
New +$180 ﹤0.01% 1354

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schubert & Co's USNA Position: Q2 2023 in Review

Schubert & Co sold out of Usana Health Sciences (USNA) in Q2 2023, closing a stake of 10 shares — an estimated $629 sold.

Schubert & Co first reported a position in USNA in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q2 2022. 169 funds tracked by Wall St. Rank hold USNA as of Q2 2023.

  • Schubert & Co reported no remaining Usana Health Sciences position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 10 Usana Health Sciences shares in Q2 2023, an estimated $629.
  • Schubert & Co first reported a position in Usana Health Sciences in Q1 2022 and held it in 5 quarters.
  • Schubert & Co's Usana Health Sciences position peaked at $1K in Q2 2022.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.